# Kineret

NDC: 66658-234
Generic name: anakinra
Labeler / Manufacturer: Swedish Orphan Biovitrum AB (publ)
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20091215

FDA application: BLA103950

## Active ingredients

- ANAKINRA: 100 mg/.67mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66658-234"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66658-234
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9d74915-6606-4570-9c52-c4001d3177de